Oscar Health, Inc. (NYSE:OSCR - Get Free Report) was up 5.3% during trading on Tuesday . The company traded as high as $21.00 and last traded at $21.25. Approximately 2,876,334 shares were traded during trading, a decline of 80% from the average daily volume of 14,417,416 shares. The stock had previously closed at $20.18.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on OSCR shares. Robert W. Baird reiterated a "neutral" rating and set a $14.00 target price (down from $28.00) on shares of Oscar Health in a research report on Friday, July 25th. Zacks Research upgraded Oscar Health from a "strong sell" rating to a "hold" rating in a report on Monday, October 13th. Barclays decreased their price target on Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a report on Wednesday, July 23rd. The Goldman Sachs Group began coverage on Oscar Health in a report on Tuesday, October 14th. They set a "neutral" rating and a $17.00 price target on the stock. Finally, Wells Fargo & Company increased their price target on Oscar Health from $10.00 to $14.00 and gave the company an "underweight" rating in a report on Tuesday, October 7th. Six equities research analysts have rated the stock with a Hold rating and six have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Reduce" and a consensus price target of $13.19.
Read Our Latest Research Report on Oscar Health
Oscar Health Stock Performance
The firm has a market cap of $5.55 billion, a PE ratio of -26.63 and a beta of 1.89. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.26. The business has a 50 day simple moving average of $18.45 and a two-hundred day simple moving average of $16.18.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, beating the consensus estimate of ($0.90) by $0.01. The firm had revenue of $2.86 billion for the quarter, compared to analyst estimates of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The business's revenue for the quarter was up 29.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.20 earnings per share. As a group, equities research analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.
Insider Activity at Oscar Health
In other news, insider Mario Schlosser sold 395,000 shares of the business's stock in a transaction dated Monday, September 22nd. The shares were sold at an average price of $18.43, for a total value of $7,279,850.00. Following the completion of the sale, the insider owned 501,148 shares in the company, valued at approximately $9,236,157.64. The trade was a 44.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 25.11% of the company's stock.
Institutional Investors Weigh In On Oscar Health
Several large investors have recently modified their holdings of the business. LRI Investments LLC boosted its position in Oscar Health by 377.9% during the second quarter. LRI Investments LLC now owns 1,233 shares of the company's stock valued at $26,000 after purchasing an additional 975 shares in the last quarter. Farther Finance Advisors LLC boosted its position in Oscar Health by 4,420.7% during the third quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company's stock valued at $25,000 after purchasing an additional 1,282 shares in the last quarter. Atlantic Union Bankshares Corp bought a new stake in Oscar Health during the second quarter valued at about $33,000. Jones Financial Companies Lllp boosted its holdings in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock worth $30,000 after acquiring an additional 2,242 shares in the last quarter. Finally, Strs Ohio acquired a new stake in Oscar Health in the first quarter worth about $30,000. Institutional investors own 75.70% of the company's stock.
About Oscar Health
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.